secwatch.observer — SEC 8-K summary
======================================

Issuer:     LeonaBio, Inc. (LONA)
CIK:        0001620463
Form:       8-K
Filed at:   2024-10-18T23:59:59+00:00
Accession:  0000950170-24-115592
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Athira Pharma receives Nasdaq bid price deficiency notice; stock below $1 for 30 days
--------------------------------------------------------------------------------

- Received Nasdaq notice on Oct 16, 2024 for non-compliance with minimum bid price of $1.00.
- Has 180 calendar days (until April 14, 2025) to regain compliance by closing at $1.00+ for 10 consecutive days.
- May seek stockholder approval for reverse stock split if needed to cure deficiency.
- Also plans to file new $300M shelf registration S-3 to replace expiring 2021 registration.
- If not compliant by deadline, may transfer to Nasdaq Capital Market for additional 180-day cure period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1620463/000095017024115592/0000950170-24-115592-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1620463/000095017024115592/atha-20241016.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-115592

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer